Harrow (HROW) Return on Capital Employed (2011 - 2026)
Harrow (HROW) posted quarterly Return on Capital Employed of 6.18% for Q1 2026, up 380.0% year-over-year from 1.29% in Q1 2025, and down 42.26% quarter-over-quarter from 10.71% in Q4 2025.
Harrow (HROW) Return on Capital Employed (2011 - 2026) Analysis & Trends
Harrow's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 6.18% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 380.0% year-over-year to 6.18%; the TTM figure through Mar 2026 stood at 6.18% (up 380.0% YoY), while the FY2025 annual figure was 10.24%, up 684.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 6.18%, down from 10.71% in the prior quarter.
- The five-year high for Return on Capital Employed was 13.62% in Q2 2025, with the low at 3.82% in Q3 2024.
- The 5-year median for Return on Capital Employed is 1.49% (2023), against an average of 2.45%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed tumbled 1737 bps in 2022, then surged 1706 bps in 2025.
- Harrow's Return on Capital Employed stood at 1.75% in 2022, then sank by 90 bps to 0.17% in 2023, then surged by 1733 bps to 3.16% in 2024, then surged by 239 bps to 10.71% in 2025, then tumbled by 42 bps to 6.18% in 2026.
- Business Quant data shows HROW's Return on Capital Employed at 6.18% in Q1 2026, 10.71% in Q4 2025, and 9.64% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn | -0.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.87% |
| Mar 31, 2026 | 6.18% |
| Dec 31, 2025 | 10.71% |
| Sep 30, 2025 | 9.64% |
| Jun 30, 2025 | 13.62% |
| Mar 31, 2025 | 2.38% |
| Dec 31, 2024 | 3.16% |
| Sep 30, 2024 | -3.82% |
| Jun 30, 2024 | -3.45% |
| Mar 31, 2024 | -2.94% |
| Dec 31, 2023 | 0.17% |
| Sep 30, 2023 | 1.49% |
| Jun 30, 2023 | 0.85% |
| Mar 31, 2023 | 0.61% |
| Dec 31, 2022 | 1.75% |
| Sep 30, 2022 | 2.42% |
| Jun 30, 2022 | -1.98% |
| Mar 31, 2022 | 0.90% |
| Dec 31, 2021 | 1.78% |
| Sep 30, 2021 | 6.35% |